O'Kane Kieran's Form 4 filing
Biodesix Inc (BDSX) · filed Feb 12, 2025
- Accession no.
- 0000905148-25-000526
- Filed
- Feb 12, 2025
- Trade date
- Feb 10-11, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 3 derivative transactions. Open-market sales total $16.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| O'Kane KieranCIK 0001828131 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2025 | Common Stock | MOption exerciseAcquired | +48,118 | – | – | 145,566 | Direct | |
| Feb 11, 2025 | Common Stock | SSaleDisposed | −17,527 | $0.92 | −$16,124.84 | 128,039 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2025 | Common Stock | MOption exerciseDisposed | −1,489 | $0.00 | $0 | 5,958 | Direct | |
| Feb 10, 2025 | Common Stock | MOption exerciseDisposed | −30,534 | $0.00 | $0 | 61,067 | Direct | |
| Feb 10, 2025 | Common Stock | MOption exerciseDisposed | −16,095 | $0.00 | $0 | 48,286 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.